Applied Biosciences Corp
OTC:APPB
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0001
0.0002
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Applied Biosciences Corp
Applied BioSciences Corp. is a vertically integrated company, which focuses on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics or biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic area. The company is headquartered in New York City, New York. The company went IPO on 2015-11-04. The firm delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. The company sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industry. The firm source products from multiple production facilities in California, Colorado, Nevada and Florida. The firm's subsidiaries include Applied Products LLC, VitaCBD LLC, Trace Analytics, Inc., and SHL Management LLC, among others.
Applied BioSciences Corp. is a vertically integrated company, which focuses on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics or biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic area. The company is headquartered in New York City, New York. The company went IPO on 2015-11-04. The firm delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. The company sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industry. The firm source products from multiple production facilities in California, Colorado, Nevada and Florida. The firm's subsidiaries include Applied Products LLC, VitaCBD LLC, Trace Analytics, Inc., and SHL Management LLC, among others.